Concurrent BK polyomavirus, adenovirus and cytomegalovirus infections in a patient treated for chronic lymphocytic leukaemia

被引:0
|
作者
Kwok, Michelle [1 ]
Lin, John [2 ]
Routy, Jean-Pierre [2 ,3 ]
机构
[1] McGill Univ, Div Internal Med, Ctr Hlth, Montreal, PQ, Canada
[2] McGill Univ, Infect Dis & Immun Global Hlth Program, Res Inst, Hlth Ctr, Montreal, PQ, Canada
[3] McGill Univ, Div Haematol, Ctr Hlth, Montreal, PQ, Canada
关键词
malignant disease and immunosuppression; drugs: infectious diseases; immunology; Malignant and Benign haematology; HEMORRHAGIC CYSTITIS; CYCLOPHOSPHAMIDE; FLUDARABINE; RITUXIMAB;
D O I
10.1136/bcr-2020-235981
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 58-year-old woman with chronic lymphocytic leukaemia (CLL) presented with 2weeks of fever and haematuria following chemo-immunotherapy. CT scan showed thickening of her left urethra and bladder, suggesting pyleo-ureteritis with cystitis. The patient was initially treated for suspected bacterial urinary tract infection although repeated blood and urine cultures remained negative. She then received multiple transfusions for chemotherapy-induced pancytopenia while her urinary symptoms did not improve. Due to her immunocompromised status, she was tested for viral infection, which revealed, BK polyomavirus, adenovirus and cytomegalovirus in serum and urine. Cidofovir was initially administered to treat these infections while ganciclovir was used with filgrastim due to neutropenia. The patient subsequently improved. This case represents a diagnostic and therapeutic challenge due to the multiple concurrent viral infections causing haematuria as well as the combined post-chemo-immunotherapy and antiviral myelotoxicity in a CLL patient.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Outcome of patients aged 80 years or older treated for chronic lymphocytic leukaemia
    Al-Sawaf, Othman
    Bahlo, Jasmin
    Robrecht, Sandra
    Fischer, Kirsten
    Herling, Carmen D.
    Hoechstetter, Manuela
    Fink, Anna-Maria
    von Tresckow, Julia
    Langerbeins, Petra
    Cramer, Paula
    Stilgenbauer, Stephan
    Wendtner, Clemens M.
    Eichhorst, Barbara
    Hallek, Michael
    Goede, Valentin
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 183 (05) : 727 - 735
  • [2] Pembrolizumab-induced autoimmune haemolytic anemia in a patient with chronic lymphocytic leukaemia successfully treated with ibrutinib
    Yun, Nicole K.
    Alrifai, Taha
    Miller, Ira J.
    Larson, Melissa L.
    BMJ CASE REPORTS, 2021, 14 (09)
  • [3] Detection of a hepatitis B surface antigen variant emerging in a patient with chronic lymphocytic leukaemia treated with fludarabine
    Alexopoulou, Alexandra
    Dourakis, Spyros P.
    Pandelidaki, Helen
    Archimandritis, Athanasios J.
    Karayiannis, Peter
    JOURNAL OF MEDICAL VIROLOGY, 2006, 78 (08) : 1043 - 1046
  • [4] Simultaneous clinical resolution of focal segmental glomerulosclerosis associated with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab
    Spyridon Arampatzis
    Nikolaos Giannakoulas
    Vassilios Liakopoulos
    Theodoros Eleftheriadis
    Panagiota Kourti
    Foteini Karasavvidou
    Panagiota Matsouka
    Ioannis Stefanidis
    BMC Nephrology, 12
  • [5] Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib
    Sun, Clare
    Tian, Xin
    Lee, Yuh Shan
    Gunti, Sreenivasulu
    Lipsky, Andrew
    Herman, Sarah E. M.
    Salem, Dalia
    Stetler-Stevenson, Maryalice
    Yuan, Constance
    Kardava, Lela
    Moir, Susan
    Maric, Irina
    Valdez, Janet
    Soto, Susan
    Marti, Gerald E.
    Farooqui, Mohammed Z.
    Notkins, Abner L.
    Wiestner, Adrian
    Aue, Georg
    BLOOD, 2015, 126 (19) : 2213 - 2219
  • [6] Serum sickness reaction to obinutuzumab in a patient with chronic lymphocytic leukaemia
    Elmanaseer, Oday
    Avelino, Alzira R. M.
    Azem, Amin
    Raval, Mihir
    BMJ CASE REPORTS, 2021, 14 (12)
  • [7] Simultaneous clinical resolution of focal segmental glomerulosclerosis associated with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab
    Arampatzis, Spyridon
    Giannakoulas, Nikolaos
    Liakopoulos, Vassilios
    Eleftheriadis, Theodoros
    Kourti, Panagiota
    Karasavvidou, Foteini
    Matsouka, Panagiota
    Stefanidis, Ioannis
    BMC NEPHROLOGY, 2011, 12
  • [8] A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia
    Hillmen, Peter
    Cohen, Dena R.
    Cocks, Kim
    Pettitt, Andrew
    Sayala, Hazem A.
    Rawstron, Andy C.
    Kennedy, Daniel B.
    Fegan, Christopher
    Milligan, Don W.
    Radford, John
    Mercieca, Jane
    Dearden, Claire
    Ezekwisili, Raphael
    Smith, Alexandra F.
    Brown, Julia
    Booth, Gillian A.
    Varghese, Abraham M.
    Pocock, Christopher
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 152 (05) : 570 - 578
  • [9] Community-acquired adenovirus pneumonia in a patient with chronic lymphatic leukaemia
    I. K. Larsen
    H. Nielsen
    European Journal of Clinical Microbiology and Infectious Diseases , 2005, 24 : 217 - 219
  • [10] Major infections, secondary cancers and autoimmune diseases occur in different clinical subsets of chronic lymphocytic leukaemia patients
    Visentin, Andrea
    Imbergamo, Silvia
    Gurrieri, Carmela
    Frezzato, Federica
    Trimarco, Valentina
    Martini, Veronica
    Severin, Filippo
    Raggi, Flavia
    Scomazzon, Edoardo
    Facco, Monica
    Piazza, Francesco
    Semenzato, Gianpietro
    Trentin, Livio
    EUROPEAN JOURNAL OF CANCER, 2017, 72 : 103 - 111